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Abstract
RhoA plays a fundamental role in regulation of the actin cytoskeleton, intercellular attachment and
cell proliferation. During amelogenesis, ameloblasts which produce the enamel proteins undergo
dramatic cytoskeletal changes and RhoA protein level is upregulated. Transgenic mice were
generated that express a dominant-negative RhoA transgene in ameloblasts using amelogenin gene
regulatory sequences. Transgenic and WT molar tooth germs were incubated with NaF or NaCl in
organ culture. F-actin stained with phalloidin was elevated significantly in WT ameloblasts treated
with NaF compared to WT ameloblasts treated with NaCl or compared to transgenic ameloblasts
treated with NaF, thereby confirming a block in the RhoA/ROCK pathway in the transgenic mice.
Little difference in quantitative fluorescence (estimation of fluorosis) was observed between WT
and transgenic incisors from mice provided NaF in their drinking water. We subsequently found
reduced transgene expression in incisors compared to molars. Transgenic molar teeth had reduced
amelogenin, E-cadherin and Ki67 compared to WT. Hypoplastic enamel in transgenic mice
correlates with reduced expression of the enamel protein amelogenin, and E-cadherin and cell
proliferation are regulated by RhoA in other tissues. Together these findings reveal deficits in
molar ameloblast function when RhoA activity is inhibited.
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Vertebrate teeth develop during a series of reciprocal interactions between epithelial and
mesenchymal cell layers within the unerupted tooth germ (1, 2). A single layer of epithelium
differentiates into ameloblast cells, which secrete enamel proteins that mineralize to form
the enamel layer on the crown of the tooth.
The morphologies of ameloblasts and their cellular precursors change continuously during
the various stages of the ameloblast life cycle, in conjunction with the changing functions of
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these cells (3). Early in development, a layer of short inner enamel epithelium participates in
signaling with the underlying dental papilla (1), which ultimately forms the adjacent
mineralized dentin layer. The inner enamel epithelium differentiates into tall secretory-stage
ameloblasts, which have an actin-rich secretory structure referred to as Tomes’ process,
from which enamel proteins are released into the developing enamel layer (4). After the full
thickness of enamel has been produced, the secretory ameloblasts undergo a transition, in
which the cells reorganize to become shorter and Tomes’ process retracts. During the
subsequent maturation stage, ameloblasts undergo a series of modulations in which the distal
cell surface adjacent to the enamel layer changes repeatedly from a smooth appearance to a
highly indented or ruffled surface (5). These changes accompany functional alterations in
transferring calcium and phosphate into developing enamel and retrieving organic material
from the enamel layer to increase mineral content. As the cell reorganizes from a short
epithelial cell, to a secretory ameloblast which can be 50 μm in height, to a shorter cell able
to alter its apical surface, to finally a protective ameloblast firmly attached to the enamel
surface by hemi-desmosomes, the actin cytoskeleton must also continuously reorganize (6,
7).
The RhoA pathway has a fundamental role in regulation of the actin cytoskeleton in both
fibroblastic and epithelial cell types (8, 9). RhoA is a well-studied member of the Rho
GTPase superfamily of small G proteins, and as a molecular switch cycles between active
and inactive forms with regulation that include GAPs (activating proteins) and GEFs
(exchange factors; 10, 11). The RhoA downstream effector ROCK (Rho associated protein
kinase) when activated increases actin stress fiber formation (12).
Filamentous actin (F-actin) in cultured fibroblasts can be elevated by treatment with high
concentrations of sodium fluoride. This occurs by inhibition of RhoGAP activity which
activates RhoA, and can be detected microscopically using phalloidin stain of intracellular
F-actin (11). We have shown that NaF can also be used as a tool to study F-actin
upregulation in ameloblasts of wild-type murine teeth in organ culture, also through the
RhoA pathway. The two-fold elevation of F-actin by NaF was diminished in the presence of
relatively specific inhibitors of ROCK including Y-27632 and fasudil (HA1077) in tooth
organ cultures (13-15), indicating the central role of the RhoA/ROCK pathway in F-actin
induction within the ameloblast cytoskeleton.
Because RhoA signals through at least 28 downstream effectors, this small G protein is able
to affect diverse cellular activities including intercellular adherens junctions, cell polarity,
proliferation and migration, as well as gene expression in various cell types (16). Regulated
intercellular attachments are thought to be important for ameloblasts to develop the cross-
hatched decussation patterns found in normal enamel (7, 17). E-cadherins have been
intensely studied because of their association with adherens junctions of ameloblasts
(18-20), and immunolocalization analyses have shown E-cadherins are abundant in
presecretory ameloblasts, reduced during secretory stage, elevated during transition and then
reduced again during maturation (21,22). Interestingly, the expression is opposite to that of
adenomatous polyposis coli (APC) in rat incisors, which is elevated during secretion and
maturation (23). RhoA is required for establishment of cadherin binding between cells (24),
and treatment of murine incisors in culture with Y27632, the ROCK inhibitor, led to weak,
abnormally distributed, E-cadherin immunostaining in ameloblasts (25), thereby further
implicating the RhoA pathway in normal activities of ameloblasts.
We and others have shown endogenous RhoA mRNA or protein is abundantly expressed in
rodent ameloblasts, increasing from newborn until PN5 (postnatal day 5) in rat molars and
until PN8 in murine molars (14, 26, 27). In order to evaluate RhoA function in
differentiating ameloblasts in vivo, a transgenic approach was developed in which
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dominant-negative T19N RhoA (28) was expressed under control of the amelogenin
regulatory sequences. This led to a transgene expression pattern similar to the endogenous
RhoA and amelogenin genes, with the goal of deregulating activities of the endogenous
RhoA protein during ameloblast secretory stage. The expression vector was planned so that
RhoADN was fused to the EGFP reporter protein, allowing expression to be localized using
immunohistochemistry to GFP. Others have shown that RhoADN is active when fused to
EGFP and that the T19N dominant negative RhoA has activity in rodents in vivo (29-31).
We hypothesized that interference with the RhoA pathway in vivo would lead to defective
dental enamel structure, and we have observed that the EGFP-RhoADN transgenic mice
develop a molar defect, where enamel is hypoplastic and disorganized at the cuspal surface
(15). Because not only ROCK but also other downstream RhoA effectors are predicted to be
affected, these transgenic mice have been analyzed to better explain the mechanism behind
the enamel defect.
MATERIAL AND METHODS
Molecular analysis of EGFP-RhoADN transgenic mice
Genomic DNA from tail tissue was analyzed by PCR from the three strains TgEGFP-
RhoADN-2, 8 and 13 as described (15). The transgene is regulated by amelogenin gene
sequences to target expression to ameloblasts. All work was performed in accordance with
regulations of the University of Pennsylvania Institutional Animal Care and Use Committee.
Organ culture and phalloidin staining
Dissected first mandibular molars from postnatal day 2 (PN2) transgenic or wild-type (WT)
mice were placed into organ culture and treated as described previously (14). Briefly, teeth
were incubated in BGJb medium (Gibco/Invitrogen, Carlsbad, CA, USA) containing 10%
fetal bovine serum with 50 μg/ml ascorbic acid to reduce toxicity. NaF or NaCl was added
to 4 mM final concentration for left or right first molars from each mouse for 30 min at
37°C. Tooth germs were immediately fixed with 4% paraformaldehyde overnight,
embedded in OCT (Tissue-Tek, Torrance, CA, USA), sectioned using a cryostat and stained
with phalloidin AlexaFluor 546 as described (14). Slides were photographed and images
were analyzed using ImageJ software (http://rsb.info.nih.gov/ij/).
Measurement of dental fluorosis by quantitative fluorescence
WT and TgEGFP-RhoADN-13 transgenic mice were provided 0, 50 or 100 ppm F ion in
drinking water as NaF for 4 weeks ad libitum beginning at PN21 (n = 6 for each group).
Mice were then euthanized and heads were frozen until analysis.
For the clinical examination, a single examiner (ETE) performed duplicate evaluations of
dental fluorosis status for each animal. The determination of dental fluorosis was made
clinically over the entire lower incisor tooth surfaces according to a modified Thylstrup &
Fejerskov (TF) index (32-37).
A quantitative fluorescence (QF) system was previously devised to evaluate the severity of
fluorosis in mice (32, 34, 38, 39). A Nikon epifluorescence microscope equipped with a
Chroma Gold 11006v2 set cube (exciter D360/40x, dichroic 400DCLP, and emitter
E515LPv2) was used to capture fluorescent images of teeth. The lower incisors were
removed from the mandible and allowed to remain slightly moist. Teeth were viewed, labial
side up and flat, on a black background at 2X magnification. Eleven-megapixel Bmp images
were acquired under standard exposure conditions. Images were analyzed with Image J
software version 1.33u (http://rsb.info/nih.gov/ij/). Briefly, ten 300 × 300 pixel areas were
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randomly positioned over the pair of lower incisors and the mean grayscale values for each
square determined. The average grayscale values for all 10 regions were then determined.
Measurement of elastic modulus and hardness
Elastic modulus and hardness of molar enamel were determined in 8 wk-old WT and
transgenic mice (n=6) by a Nanoindenter XP (MTS Systems, Oak Ridge, TN, USA). Half-
mandibles were embedded in Acrymount embedding resin (Electron Microscopy Sciences,
Hatfield, PA, USA) and polished mesial-distally with 400-grit silicon carbide paper to reveal
longitudinal cross-sections of molars, perpendicular to the orientation of enamel prisms.
Embedded mandibles were further polished to 0.25 μm with diamond paste. Nano-
indentations were performed with a Berkovich diamond tip, under dry conditions, with a
trapezoidal force profile with peak loads at 300 μN. Twenty indentations were made in the
enamel of each tooth in mesial cusps of first molars. Each indentation yielded a load-
deformation curve, from which the elastic modulus, E, and hardness, H, were determined
according to the following equations (40):
where S represents the slope of the unloading curve based on the method of Oliver & Pharr
(41), a is the indentation contact area, and Fmax is the maximum force.
Immunohistochemistry
Mandibles dissected from PN 1-8 WT and TgEGFP-RhoADN-13 mice were fixed in 4%
paraformaldehyde, demineralized in 5% EDTA when necessary and embedded in paraffin.
One 5 μm section was stained with hematoxylin and eosin (H&E), and other sections were
incubated with peroxide in PBS followed by anti-GFP (Ab6556, Abcam, Cambridge, MA,
USA). An adjacent control section was incubated without primary antibody. After washing,
the sections were incubated with secondary antibody (Vectastain ABC kit PK-4001, Vector
Laboratories, Burlingame, CA, USA) and DAB substrate (Vector Laboratories). WT and
transgene negative mice served as negative controls.
Immunohistochemistry studies for E-cadherin and Ki67 were performed similarly using
1:200 dilution of anti-E-cadherin (24E10, Cell Signaling Technology, Danvers, MA, USA)
or 1:5000 of anti-Ki67 (ab15580) (Abcam) followed by the Vectastain procedures described
above.
Western blots
Two mandibular first molar teeth from PN4 pups of WT and each transgenic strain were
dissected and proteins were extracted; blots were prepared as described (42). Membranes
were incubated with anti-GFP antibody (Ab6556, Abcam) at 1:1000 dilution and goat anti-
rabbit secondary antibody (Thermo-Fisher, Rockford, IL, USA) at 1:2000 dilution.
Additional membranes were probed with anti-RhoA (67B9#2117, Cell Signaling
Technology) at 1:1000 dilution and goat anti-rabbit antibody, and reprobed without stripping
with anti-actin antibody (A2103, Sigma, St. Louis, MO, USA). Western blots were prepared
similarly to compare molar and incisor transgene expression, except 10 μg was loaded onto
each lane of the gel.
For detection of amelogenin, anti-amelogenin (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) and anti-GAPDH (Cell Signaling Technology) at 1:1000 dilution were used with
enamel organ extracts as described (27). Bands were scanned for normalization using
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ImageJ software (43). For the Western blot of transgenic protein amounts in mandibular first
molars and incisors, 10 μg of extract from each tooth type from PN4 mice was compared
using anti-GFP antibody as described above.
Statistics
Statistical significance was assessed using ANOVA with Bonferroni’s multiple comparison
test, with significance defined as P<0.05 (GraphPad Prism 5, Graph Pad Software, San
Diego, CA, USA).
RESULTS
Three founders were generated that express RhoADN
Three founder mice identified by PCR of tail genomic DNA were mated with C57BL/6J WT
mice to generate independent strains, TgEGFP-RhoADN-2, -8 and -13. In order to compare
transgene expression among the three strains, extracts of molar teeth were prepared for SDS-
PAGE, including transgene negative, WT and transgene positive molars. The Western blots
probed with anti-RhoA antibody identified the EGFP-RhoADN fusion protein at 48 kDa in
the three transgenic strains plus the endogenous RhoA protein visible at 22 kDa for all mice
(Fig. 1). Blots were also probed for GFP, and the antibody detected the identical transgenic
fusion protein at 55-60 kDa in the 3 transgenic extracts (not shown). Membranes were re-
probed with anti-actin antibody for normalization. Quantitation indicated that strain
TgEGFP-RhoADN-13 had the highest expression, strain -8 had the lowest and strain -2 was
intermediate.
RhoADN expression during molar development
Transgenic and WT mandibles were also prepared for reporter protein localization.
Immunohistochemistry using anti-GFP antibodies revealed staining of the ameloblast layer
beginning at PN2 which became intense at PN3 and PN4 (Fig. 2A-D). Expression decreased
at molar cusp tips at PN6 and localized only to the cervical loop region by PN8 (Fig. 2E,F),
in agreement with Western analysis (27). Staining was negligible when primary antibody
was omitted.
Organ culture revealed the dominant negative effects of the transgene
In order to determine whether the dominant negative transgene could inhibit F-actin
elevation by NaF, first molar tooth germs were dissected and placed into organ culture in the
presence of 4 mM NaF or NaCl. For all three strains, RhoA activity was indirectly assessed
under identical conditions by phalloidin staining of ameloblast F-actin, by generating images
of the ameloblasts under fluorescent microscopy (14, 15). WT molars treated with NaF had
greater phalloidin staining intensity in ameloblasts compared to WT ameloblasts in molars
treated with NaCl (P<0.0001), or in molar ameloblasts from each transgenic strain treated
with NaF (P<0.0001), consistent with the block to the RhoA pathway in the three transgenic
strains (Fig. 3).
For subsequent studies, the TgEGFP-RhoADN-13 (referred to as E13) mice were used due to
the higher transgene expression level, as we are unable to precisely measure the amount of
dominant negative activity required for an informative phenotype to develop.
Quantitative fluorescence
WT and transgenic mice were given NaF in their drinking water in order to determine
whether the dominant negative RhoA could alter the fluorotic phenotype in incisor enamel.
WT and TgEGFP-RhoADN-13 mice were given 0, 50 or 100 ppm F ion as NaF in their
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drinking water for 4 wk. The clinical images of an example of each treatment and genotype
are shown in Fig. 4. In the mandibular incisors and less so in the maxillary incisors, dental
fluorosis developed similarly when comparing WT and TgEGFP-RhoDN-13 mice.
Quantitative fluorescence (QF) results in Fig. 5 show a dose dependent increase in dental
fluorosis for WT and TgEGFP-RhoADN-13 mice. QF was significantly different comparing
WT and transgenic incisor controls (0 ppm) to 100 ppm [F-] (P<0.001), but no statistically
significant differences were observed between WT and TgEGFP-RhoADN mice treated at
0ppm or 100ppm [F-]. However, at 50 ppm, QF was higher for TgEGFP-RhoADN mice
compared to WT (P<0.05).
To better understand why WT and transgenic mice treated with 100 ppm F- had similar QF
values for incisors, we questioned whether the transgene was expressed at a lower level in
incisors compared to molars. Western blots indicated elevated transgene expression in
molars compared to incisors (Fig. 6) consistent with the QF results described above,
although RT-PCR detected a low transgene expression in incisors. The reduction in incisor
expression was greater than observed with other transgenic mice based on this vector system
(42, 44). Subsequent transgenic studies focused on the developing molar.
Structural properties of enamel
Transgenic molar enamel elastic modulus trended somewhat lower and nanohardness
somewhat higher compared to WT, but these differences were not statistically significant
(Table 1). These nanoindentation measurements were made on cross sections of molar teeth
from the enamel surface and ending at the dentin-enamel junction, as described in Material
and Methods.
Ameloblasts are altered in transgenic mice
By Western analysis, amelogenin proteins were reduced in transgenic molar enamel organs
compared with WT, with statistical significance (P<0.001) at PN2 and 4 (Fig. 7A-C). This is
in agreement with the observed enamel hypoplasia in these transgenic mice, as reduced
amelogenin also led to enamel hypoplasia in molars from amelogenin null or partially
rescued mice (42, 45).
Immunohistochemistry for ameloblast E-cadherin invariably showed less staining in
transgenic mandibular or maxillary molars compared to WT molars from mice of identical
age and weight (Fig. 8A-E). These comparisons were performed with six independent pairs
of age/weight matched mice with similar results. In addition, a difference was observed in
Ki67 immunostaining at PN2-3, which is an indicator of cells undergoing DNA synthesis,
linked with cell proliferation (46). In each set of paired samples, WT molars had more
positive presecretory ameloblasts than transgenic molars (Fig. 9A-E).
DISCUSSION
The RhoA pathway is critical for dynamic re-organization of the actin cytoskeleton and
ameloblasts are unique in that their cell shapes continually change during their life cycle and
these morphological changes are linked with functional changes. RhoA protein is induced
during differentiation of WT murine ameloblasts, and the Rho inhibitor RhoGDI normally
decreases in ameloblasts as enamel protein expression begins, presumably to direct RhoA
activation (47). To test the importance of the RhoA pathway during enamel formation, we
generated mice that express RhoADN protein in secretory ameloblasts during enamel
development. The dominant negative T19N mutation allows binding to RhoGEFs, but
reduces downstream target interactions (48).
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Previously, cultured fibroblasts had been treated with NaF, which interferes with RhoGAP
and elevates RhoA activity (11), and F-actin was increased. Similarly, in tooth germs treated
with NaF in organ culture and stained with phalloidin, F-actin was visualized by confocal
microscopy and a doubling of F-actin was measured in WT ameloblasts (14). The increase
in F-actin was reduced by Y-27632 or fasudil (HA1077) (14, 15), inhibitors of the RhoA
downstream target ROCK (12). We hypothesized that RhoA also has a role during normal
enamel development related to regulation of ameloblast activities.
Three transgenic lines of mice are described in which RhoADN was expressed at different
levels in molar ameloblasts. The molar tooth germs from each strain were placed into organ
culture as described above with NaF or NaCl, and while the WT ameloblasts had elevated F-
actin in the presence of NaF, the transgenic ameloblasts had no increase. This illustrated the
dominant negative block to F-actin induction in the transgenic mice, similar to results shown
in the presence of NaF plus ROCK inhibitors in WT ameloblasts in organ culture.
An enamel surface defect is present prior to molar eruption in these transgenic mice, and all
3 transgenic strains have hypoplastic molar enamel (42). Previously, we reported that the
transgene was highly expressed in molars at PN4, but decreased at PN8, as expected due to
regulation by amelogenin gene sequences. ROCK activity was elevated at PN6 and PN8 in
WT mice, but reduced to less than half the WT level in TgEGFP-RhoADN-13 ameloblasts
(27). Because the QF results presented here led us to ascertain that molars expressed higher
levels of transgene than incisors, and that molar expression begins by PN2 and is elevated
on PN3 and PN4, transgene expression in this mouse model would be expected to have
impacts on events primarily during molar secretory stage. The elevated QF results for
incisors of transgenic mice treated with 50 ppm F- were surprising; future experimentation
may lead to a better understanding of this finding.
Amelogenins are the principal enamel proteins expressed during the secretory stage of
ameloblasts (49). TgEGFP-RhoADN-13 mice have significantly reduced amelogenin during
secretory stage when the RhoADN transgene expression is elevated, and at 8 weeks of age,
mice have enamel hypoplasia (15). When developing WT teeth were incubated with ROCK
inhibitor Y-27632, amelogenin mRNA and protein were both reduced (25, 26). Together,
these findings strengthen the conclusion that RhoA pathway elements can regulate aspects
of enamel development.
RhoA signaling elevates filamentous actin (F-actin), which is localized primarily to
ameloblast intercellular binding sites and Tomes’ process (6). Adherens junctions are linked
to actin filaments and thought to participate in cellular interactions that generate sliding rows
of ameloblasts during development, leading to unique enamel decussation patterns (7, 3).
Cadherin levels normally decrease and increase cyclically during incisor ameloblast
differentiation presumably to allow efficient cellular reorganization (19, 22). β-catenin is
also linked to adherens junctions, and was previously shown to be elevated in PN4
transgenic molar ameloblasts (43). Although associated with junctional complexes, β-
catenin also can migrate to the nucleus to direct gene transcription (50). This elevation of β-
catenin in the transgenic ameloblasts may be linked to activation of Wnt pathway elements,
known to be important during normal tooth development (27, 51).
Cellular polarity was unaffected in transgenic ameloblasts, perhaps because by the time
transgene expression was elevated, intercellular contacts had been firmly established. The
decrease in Ki67 positive cells also would indicate that polarity could be established early in
the transgenic mice. Over-expressed RhoA elevates proliferation and migration of tumor
cells while siRNA mediated reduction in RhoA inhibits both activities (52, 53). Inactivation
of RhoA can lead to increase or inhibition of cell proliferation in different cell types (54,
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55). Reduction in endogenous RhoA by various means has been associated with weakening
of the cadherin-based contacts in other models (24, 55, 56), which may explain lower E-
cadherin levels observed by immunohistochemistry in transgenic ameloblasts compared to
WT. The structural alterations at tips of molar cusps in transgenic mice correspond to
expression during mid to late secretory stage, and it is assumed that enamel secretion was
altered prior to PN8 when transgene expression was again reduced and cells entered
maturation stage (15).
In summary, we provide further support that RhoA has a role in generation of a normal
enamel layer by ameloblasts. We show that in the presence of a dominant negative RhoA,
amelogenin protein was reduced, which correlates with hypoplastic enamel. Expression of
the transgene led to reduction in RhoA/ROCK activity, and elevated β-catenin levels
previously noted (27) were also temporally linked with reduced E-cadherin and reduced
DNA synthesis in ameloblasts. E-cadherin, p120 catenin, β-catenin and ROCK are
components of adherens junctions (24, 57-59), which are intercellular attachment sites,
thought to be critically important for the precise dynamic alterations between ameloblasts
during generation of the decussating enamel rod patterns found in mature enamel of erupted
teeth. We predict that these mice will provide a valuable tool to further dissect the role of the
RhoA pathway during amelogenesis as they present a phenotype linked to critical events
occurring during several days of the ameloblast secretory stage when the transgene is highly
expressed.
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Fig. 1. Transgene expression in developing molar teeth
Western blot of extracts of first mandibular molar teeth probed with anti-RhoA antibody.
Transgenic bands are visible at approximately 48 kDa for TgEGFP-RhoADN-2, 8 and 13
(E2, E8, E13) and all mice have endogenous RhoA at 22 kDa; anti-actin was used for
normalization. Quantitation from two independent experiments indicated TgEGFP-
RhoADN-2 (E2) expressed 35% and TgEGFP-RhoADN-8 (E8) expressed 20% of TgEGFP-
RhoADN-13 (E13) transgenic protein.
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Fig. 2. Immunohistochemistry localizes transgenic protein to ameloblasts during the secretory
stage of enamel development
Sections from first mandibular molars from TgEGFP-RhoADN-13 mice were incubated with
anti-GFP antibody at postnatal days PN1 (A), PN2 (B), PN3 (C), PN4 (D), PN6 (E) and PN8
(F). Scale bars = 100 μm.
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Fig. 3. Organ culture demonstrates effectiveness of the dominant negative mutation in 3
transgenic lines
First mandibular molar teeth from WT or TgEGFP-RhoADN-2, 8 or 13 (E2, E8, E13)
transgenic lines were placed into organ culture and treated with 4mM NaCl or NaF for 30
min. Following phalloidin staining of sections, fluorescence relative intensities of
ameloblasts were quantitated. For each comparison, bar 1: WT, NaCl; bar 2: WT, NaF; bar
3: transgenic, NaCl; bar 4: transgenic, NaF. The * indicates significant difference between
WT treated with NaF and either WT treated with NaCl or transgenic treated with NaF
(P<0.0001).
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Fig. 4. Dental fluorosis assessment of incisor teeth
Clinical images of mandibular incisors. WT (W) and TgEGFP-RhoADN-13 (E) mice were
provided drinking water for 4 weeks containing 0, 50 or 100 ppm F ad libitum.
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Fig. 5. Quantitative fluorescence (QF) of mandibular incisors
Results are shown for each treatment/control group and genotype shown in Fig. 4. *Results
significantly different from controls.
Li et al. Page 16













Fig. 6. Western blot to compare transgene expression in mandibular molar and incisor
Extracts of PN4 transgenic teeth (10 μg per lane) were probed with anti-GFP antibody. M:
molar; In: incisor.
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Fig. 7. Amelogenin is reduced in TgEGFP-RhoADN-13 teeth, by Western blot
A. Quantitation of normalized band intensity, where * indicates statistical difference from
controls (P<0.001 at PN 2 and 4). W0 to W8 are PN ages for WT mice; E0 to E8 are PN
ages for TgEGFP-RhoADN-13 mice. B. Western blot using anti-amelogenin antibody to
detect amelogenin proteins from enamel organs from mice at the indicated ages; C.
Normalization using anti-GAPDH for PN0 through PN8 for WT and transgenic mice.
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Fig. 8. E-cadherin immunostaining of ameloblasts from WT and TgEGFP-RhoADN-13 mice
Mandibular first molars (B-C) and maxillary second molars (D-E) from PN4 mice were
stained with anti-E-cadherin antibody. A: First molar control lacking primary antibody; B,D:
WT, anti-E-cadherin; C,E: TgEGFP-RhoADN-13, anti-E-cadherin. Scale bar = 200 μm.
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Fig. 9. Ki67 labels fewer ameloblast nuclei in TgEGFP-RhoADN-13 transgenic compared to WT
first mandibular molars from mice of the same age
Mandibular PN3 (A,B,E) and maxillary PN2 (C,D) first molars. A,C: WT, anti-Ki67; B,D:
TgEGFP-RhoADN-13, anti-Ki67; E: control lacking primary antibody. Dark nuclei represent
Ki67 positive ameloblasts in magnified inserts. Scale bar = 200 μm.
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Table
Elastic Modulus and Hardness in Molar Enamel
WT Enamel E13 Enamel
Elastic Modulus (GPa) 56.7 ± 17.9 49.2 ± 18.7
Hardness (GPa) 2.85 ± 1.14 3.08 ± 1.48
Legend: Nanoindentation performed in cross sections of enamel from the surface to the dentin-enamel junction of the mesial cusps of molars from
8 week old wild-type (WT) and TgEGFP-RhoADN-13 (E13) mice. n=6 independent mice with one molar per mouse measured at 20 locations.
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